KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for AbCellera Biologics (ABCL) over the last 6 years, with Dec 2024 value amounting to $295.4 million.

  • AbCellera Biologics' Shares Outstanding (Weighted Average) rose 1.41% to $298.8 million in Q3 2025 from the same period last year, while for Sep 2023 it was $289.4 million, marking a year-over-year increase of 1.48%. This contributed to the annual value of $295.4 million for FY2024, which is 1.79% up from last year.
  • As of FY2024, AbCellera Biologics' Shares Outstanding (Weighted Average) stood at $295.4 million, which was up 1.79% from $290.2 million recorded in FY2023.
  • In the past 5 years, AbCellera Biologics' Shares Outstanding (Weighted Average) registered a high of $295.4 million during FY2024, and its lowest value of $266.0 million during FY2020.
  • Over the past 3 years, AbCellera Biologics' median Shares Outstanding (Weighted Average) value was $290.2 million (recorded in 2023), while the average stood at $290.5 million.
  • Data for AbCellera Biologics' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 5.88% (in 2021) over the last 5 years.
  • AbCellera Biologics' Shares Outstanding (Weighted Average) (Yearly) stood at $266.0 million in 2020, then increased by 5.88% to $281.6 million in 2021, then grew by 1.60% to $286.1 million in 2022, then increased by 1.42% to $290.2 million in 2023, then grew by 1.79% to $295.4 million in 2024.